Day: September 16, 2025

TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) (“Constellation” or “CSI”) announced today it will host a live shareholder question and answer audio webcast on September 22, 2025 at 9:00 a.m. ET. regarding the impact of Artificial Intelligence technologies (“AI”) on software businesses. Mark Leonard, President of Constellation, said: “One of our largest shareholders asked CSI for a question and answer session regarding AI’s impact on software businesses.  We felt that the discussion would inevitably turn from the general to the CSI-specific, so we suggested a webcast where all shareholders would be able to pose questions.  This is a nice example of an enterprising shareholder catalysing corporate action that benefits all shareholders.  AI has created uncertainty for our employees, shareholders and...

Sampo plc, press release, 16 September 2025 at 6.10 pm EEST NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA (the United States) OR IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE OR TO WHOM IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT Sampo prices the issuance of new Restricted Tier 1 notes Sampo plc has today successfully priced the offering of EUR 300 million of euro-denominated fixed rate reset perpetual restricted tier 1 notes (the Notes). The Notes have an initial coupon rate of 5.250 per cent up to the first reset date on 24 September 2035. The first call date is 24 March 2035. The new issuance is...

Brings Over 25 years of Global Financial and Operational Leadership Experience Across Multiple Industries FREDERICK, Md., Sept. 16, 2025 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced the appointment of Mr. Francesco Fragasso to its Board of Directors, effective immediately. Mr. Fragasso will also serve on the Audit Committee, Compensation Committee, and Nominating and Governance Committee. He succeeds Mr. Walter Johnsen, who has resigned from the Board effective upon the appointment of Mr. Fragasso. Mr. Fragasso brings more than 25 years of global financial and operational leadership experience across multiple...

All 172 patients have now entered the 12-month follow-up phase Trial involves larger surface areas, building on the approval in October 2024 for use of up to 3 tubes of Ameluz® per treatment Study results expected to form the basis of a supplemental New Drug Application (sNDA) planned for submission in Q2 2026WOBURN, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced that the final patient completed the active treatment phase of its Phase 3 clinical trial evaluating Ameluz® (10% 5-aminolevulinic acid hydrochloride gel) PDT for mild to moderate actinic keratoses (AKs) on the extremities, neck and trunk on September 3, 2025. All 172 enrolled patients...